Investigational fibroblast growth factor receptor 2 antagonists in early phase clinical trials to treat solid tumors

Investigational fibroblast growth factor receptor 2 antagonists in early phase clinical trials to treat solid tumors
复制标题

DOI:
10.1080/13543784.2019.1672655
复制
发表时间:
2019
期刊:
Expert Opinion on Investigational Drugs
影响因子:
--
通讯作者:
Zhang Yi
Zhang Yi
中科院分区:
--
文献类型:
--
作者:
Wang Dan;Yang Li;Yu Weina;Zhang Yi

文献摘要

相似文献